Terms: = Ovarian cancer AND MAP2K2, MEK2, 5605, ENSG00000126934, P36507, MKK2, MAPKK2, PRKMK2
5 results:
1. Inhibition of USP21 leads to ovarian carcinoma cell death by suppressing MAPK signaling.
Sun X; Yu J; Cui X; Tang Y; Yu Y
Biotechnol Appl Biochem; 2024 Feb; 71(1):232-239. PubMed ID: 37964466
[TBL] [Abstract] [Full Text] [Related]
2. Expression patterns of kinin-dependent genes in endometrial cancer.
Orchel J; Witek L; Kimsa M; Strzalka-Mrozik B; Kimsa M; Olejek A; Mazurek U
Int J Gynecol Cancer; 2012 Jul; 22(6):937-44. PubMed ID: 22706224
[TBL] [Abstract] [Full Text] [Related]
3. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
[TBL] [Abstract] [Full Text] [Related]
4. Mutation analysis of BRAF, MEK1 and mek2 in 15 ovarian cancer cell lines: implications for therapy.
Estep AL; Palmer C; McCormick F; Rauen KA
PLoS One; 2007 Dec; 2(12):e1279. PubMed ID: 18060073
[TBL] [Abstract] [Full Text] [Related]
5. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract] [Full Text] [Related]
